Masters Capital Management’s CVS Health CVS Stock Holding History

Masters Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$51.7M	Hold	500,000	–	–	1.33%	21
2026 Q1	$35.9M	Buy	+500,000	New	+$38.5M	1.19%	28
2025 Q1	–	Sell	-1,000,000	Closed	-$44.9M	–	73
2024 Q4	$44.9M	Buy	1,000,000 +500,000	+100%	+$28.1M	1.66%	22
2024 Q3	$31.4M	Buy	+500,000	New	+$29.2M	1.53%	17
2023 Q4	–	Sell	-1,000,000	Closed	-$69.8M	–	67
2023 Q3	$69.8M	Sell	1,000,000 -500,000	-33%	-$35.4M	3.87%	8
2023 Q2	$104M	Buy	+1,500,000	New	+$107M	4.15%	7
2020 Q2	–	Sell	-2,500,000	Closed	-$148M	–	53
2020 Q1	$148M	Buy	2,500,000 +1,547,000	+162%	+$103M	17.22%	1
2019 Q4	$70.8M	Sell	953,000 -47,000	-5%	-$3.3M	4.02%	3
2019 Q3	$63.1M	Buy	+1,000,000	New	+$59.3M	3.75%	6
2019 Q2	–	Sell	-1,000,000	Closed	-$53.9M	–	65
2019 Q1	$53.9M	Buy	+1,000,000	New	+$61.7M	2.88%	8
2018 Q4	–	Sell	-500,000	Closed	-$39.4M	–	60
2018 Q3	$39.4M	Buy	+500,000	New	+$35.7M	0.97%	33

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Masters Capital Management's CVS Position: Q4 2019 in Review

Masters Capital Management sold out of CVS Health (CVS) in Q4 2019, closing a stake of 100,000 shares — an estimated $7.02M sold.

Masters Capital Management first reported a position in CVS in Q3 2019 and held it in 1 quarter. The position peaked at $6.31M in Q3 2019. 1,844 funds tracked by Wall St. Rank hold CVS as of Q4 2019.

Masters Capital Management reported no remaining CVS Health position as of Q4 2019 after selling out during the quarter.
Masters Capital Management sold 100,000 CVS Health shares in Q4 2019, an estimated $7.02M.
Masters Capital Management first reported a position in CVS Health in Q3 2019 and held it in 1 quarter.
Masters Capital Management's CVS Health position peaked at $6.31M in Q3 2019.
1,844 funds tracked by Wall St. Rank held CVS Health as of Q4 2019.

Based on Masters Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.